The nation's largest pharmacy benefits manager is throwing its weight into a fight over the high cost of treating hepatitis C, saying it will cover a drug from AbbVie.
12/22/14 - 01:57 PM EST
CVS Health expanded its Minute Clinic and quit selling cigarettes, while Walgreen still sells smokes and will move to the Nasdaq after completing a merger. Here's how to trade them.
12/22/14 - 01:34 PM EST
Stocks were making an effort to extend last week's big rally but struggled to move much higher in midday trading Monday.
12/22/14 - 11:48 AM EST
These Achillion results aren't great because the speed at which drugs kill the hepatitis C virus matters. Slower-acting drugs leave patients vulnerable to viral rebound or relapse.
12/22/14 - 11:36 AM EST
AbbVie strikes an exclusive deal with Express Scripts to exclusively distribute AbbVie's hepatitis C therapy. Here's what analysts said.
12/22/14 - 11:20 AM EST
Stocks eyed further gains at Monday's opening bell on this shortened trading week.
12/22/14 - 09:55 AM EST
Which biotech and pharmaceuticals stocks should investors buy in 2015? JPMorgan named six companies with the best investment cases as part of its top U.S. stocks picks for 2015.
12/22/14 - 08:23 AM EST
The power to control drug prices in the U.S. now has shifted firmly to cost-cutting insurance carriers and pharmacy benefit managers and away from biotech and drug companies.
12/22/14 - 06:14 AM EST
- Tickers in this article:
For the week of December 22nd 2014, Wall Street will be on a holiday schedule.
12/21/14 - 12:00 PM EST
U.S. regulators approved a new hepatitis C therapy from Abbvie, heralding a new era of market competition with Gilead Sciences.
12/19/14 - 04:16 PM EST
Walgreen reports its latest quarterly results next week and Jim Cramer believes it will be a key item to watch.
12/19/14 - 12:06 PM EST
Stephanie Link picks baskets of stocks that diversified within the sector itself and says that will be applied to her 2015 Healthcare picks.
12/19/14 - 11:00 AM EST